<SEC-DOCUMENT>0001178913-21-002338.txt : 20210722
<SEC-HEADER>0001178913-21-002338.hdr.sgml : 20210722
<ACCEPTANCE-DATETIME>20210722083012
ACCESSION NUMBER:		0001178913-21-002338
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210722
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
FILED AS OF DATE:		20210722
DATE AS OF CHANGE:		20210722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		211106101

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zk2126316.htm
<DESCRIPTION>8-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.5.1.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader">
      <div style="text-align: center; line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">WASHINGTON, D.C. 20549</div>
    <div style="line-height: 1.25;">&#160;&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">FORM&#160;8-K</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CURRENT REPORT</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Pursuant to Section&#160;13 or 15(d)</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">of the Securities Exchange Act of 1934</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Date of Report (Date of earliest event reported): July 22, 2021 (July 19, 2021)</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">Chemomab Therapeutics Ltd.</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Exact name of Registrant as Specified in Its Charter)</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z4de9e60b00ef49cbba7f7ca991ad212b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">State of Israel</div>
          </td>
          <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">001-38807</div>
          </td>
          <td style="width: 32.98%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">81-3676773</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(State or Other Jurisdiction</div>
          </td>
          <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Commission</div>
          </td>
          <td style="width: 32.98%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(IRS Employer</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">of Incorporation)</div>
          </td>
          <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">File Number)</div>
          </td>
          <td style="width: 32.98%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Identification No.)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="ze2262f43e5564337bec1278dd373dd9e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Kiryat Atidim, Building 7</div>
          </td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Tel Aviv,&#160;Israel</div>
          </td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">6158002</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Address of principal executive offices)</div>
          </td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Zip Code)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Registrant&#8217;s telephone number, including area code: +972-77-331-0156</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Former name or former address, if changed since last report)</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z13af1eaacf21428c9707183b9dd986e8" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5.66%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 94.34%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.66%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 94.34%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.66%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 94.34%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.66%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 94.34%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.66%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 94.34%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.66%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 94.34%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.66%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>&#9744;</div>
          </td>
          <td style="width: 94.34%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9b2e47ebdea2404bb3d66d9c368c0b1b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td nowrap="nowrap" style="width: 70.96%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Title of each class</div>
          </td>
          <td style="width: 0.55%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 9.44%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Trading<br>
              Symbol(s)</div>
          </td>
          <td style="width: 0.55%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 18.5%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Name of each<br>
              exchange<br>
              on&#160;which&#160;registered</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70.96%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">American Depositary Shares, each representing twenty (20) ordinary </div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">shares, no par value per share</div>
          </td>
          <td style="width: 0.55%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 9.44%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">CMMB</div>
          </td>
          <td style="width: 0.55%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 18.5%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Nasdaq Capital<br>
              Market</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70.96%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.55%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 9.44%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 0.55%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 18.5%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 70.96%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Ordinary shares, no par value per share</div>
          </td>
          <td style="width: 0.55%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 9.44%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">N/A</div>
          </td>
          <td style="width: 0.55%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 18.5%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Nasdaq Capital<br>
              Market*</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">* Not for trading; only in connection with the registration of American Depositary Shares.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934
      (&#167;&#160;240.12b-2 of this chapter).</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">Emerging growth company&#160; &#9746;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%- % -%-->
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to
      Section&#160;13(a)&#160;of the Exchange Act.&#160; &#9744;</div>
    <div style="line-height: 1.25;">&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z303a546cca534761947adea93a791c8b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td rowspan="1" style="width: 8%; vertical-align: top;">
            <div style="line-height: 1.25; font-weight: bold;">Item 5.07.&#160;&#160;&#160; Submission of Matters to a Vote of Security Holders.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">2021 Annual Meeting of Shareholders</font>&#160;</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On July 19, 2021, Chemomab Therapeutics Ltd. (the &#8220;Company&#8221;) held its 2021 Annual Meeting of Shareholders (the
        &#8220;Annual Meeting&#8221;). There were 103,996,920 ordinary shares of the Company represented in person or by proxy at the Annual Meeting, constituting approximately 47.26% of the outstanding ordinary shares on June 14, 2021, the record date for the Annual
        Meeting.</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The matters voted upon at the Annual Meeting and the final results of such voting are set forth below:</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Proposal 1: To approve the updated Compensation Policy for executives and directors, which shall be effective for a period of three years
      from the date of its approval.</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z393ef5edf1844202ad10520d0131d22c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 34.09%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">FOR</div>
          </td>
          <td style="width: 1.87%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 31.08%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">AGAINST</div>
          </td>
          <td style="width: 1.87%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 31.08%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">ABSTAIN</div>
          </td>
        </tr>
        <tr>
          <td style="width: 34.09%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">103,259,980</div>
            </div>
          </td>
          <td style="width: 1.87%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
          <td style="width: 31.08%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">517,180</div>
          </td>
          <td style="width: 1.87%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
          <td style="width: 31.08%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">140,640</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Additionally, out of the total votes cast, there were 101,205,200 votes &#8220;FOR&#8221; and 517,180 votes cast &#8220;AGAINST&#8221; with
        respect to Proposal No. 1 that were cast by shareholders who are not controlling shareholders and do not have a personal interest in the proposal. Accordingly, the requisite majority required under the Israeli Companies Law, 5759-1999 (the
        &#8220;Companies Law&#8221;) was satisfied for this Proposal No. 1.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company&#8217;s updated Compensation Policy for directors and officers that was approved pursuant to Proposal 1 was attached as <u>Appendix A</u> to the Company&#8217;s definitive proxy
      statement filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 14, 2021 (the &#8220;Proxy Statement&#8221;).</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Proposal 2: To approve an amendment to the terms of engagement of Dr. Adi Mor, the Company&#8217;s Chief Executive Officer.</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z91f8444b8ce741258135bdda5b0cb843" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 34.09%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">FOR</div>
          </td>
          <td style="width: 1.87%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 31.08%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">AGAINST</div>
          </td>
          <td style="width: 1.87%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 31.08%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">ABSTAIN</div>
          </td>
        </tr>
        <tr>
          <td style="width: 34.09%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">103,495,100</div>
            </div>
          </td>
          <td style="width: 1.87%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
          <td style="width: 31.08%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">300,600</div>
          </td>
          <td style="width: 1.87%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
          <td style="width: 31.08%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">120,980</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Additionally, out of the total votes cast, there were 101,490,780 votes &#8220;FOR&#8221; and 300,600 votes cast &#8220;AGAINST&#8221; with
        respect to Proposal No. 2 that&#160; were cast by shareholders who are not controlling shareholders and do not have a personal interest in the proposal. Accordingly, the requisite majority required under the Companies Law was satisfied for this Proposal
        No. 2.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The amendment to the terms of engagement of Dr. Adi Mor, the Company&#8217;s Chief Executive Officer, which was approved under Proposal 2 is further described in the Proxy Statement.</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Proposal 3: To approve an amendment to the Chemomab Ltd. Share Incentive Plan (the &#8220;2015 Plan&#8221;) to increase the aggregate number of shares
      authorized for issuance under the 2015 Plan by 540,000 ADSs or 10,800,000&#160;ordinary shares.</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf9900d93d2994af0a6c25eb0973fee2e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 34.09%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">FOR</div>
          </td>
          <td style="width: 1.87%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 31.08%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">AGAINST</div>
          </td>
          <td style="width: 1.87%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 31.08%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">ABSTAIN</div>
          </td>
        </tr>
        <tr>
          <td style="width: 34.09%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">103,184,280</div>
            </div>
          </td>
          <td style="width: 1.87%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
          <td style="width: 31.08%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">791,220</div>
          </td>
          <td style="width: 1.87%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
          <td style="width: 31.08%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">21,420</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;">Proposal 4: The approval of the reappointment of Somekh Chaikin, a member of KPMG International, as the Company&#8217;s independent auditors and to authorize the board
      of directors of the Company to delegate to the audit committee the authority to fix the said independent auditors&#8217; remuneration in accordance with the volume and nature of their services.</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9f9f8e39eab94a3aae7a256d639c2931" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 34.09%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">FOR</div>
          </td>
          <td style="width: 1.87%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 31.08%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">AGAINST</div>
          </td>
          <td style="width: 1.87%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 31.08%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;">ABSTAIN</div>
          </td>
        </tr>
        <tr>
          <td style="width: 34.09%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">103,862,300</div>
            </div>
          </td>
          <td style="width: 1.87%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
          <td style="width: 31.08%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">47,020</div>
          </td>
          <td style="width: 1.87%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
          <td style="width: 31.08%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">87,600</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 2 -</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURE</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="zc9b123e7640b4088ab2990606fc4a16c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49.54%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="vertical-align: bottom;" colspan="2">
            <div style="line-height: 1.25; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
          </td>
          <td style="width: 14%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.54%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 3%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 32.75%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 14%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.54%; vertical-align: top;">
            <div style="line-height: 1.25; font-weight: bold;">Date: July 22, 2021</div>
          </td>
          <td style="width: 3%; vertical-align: top;">
            <div style="line-height: 1.25; font-weight: bold;">By:</div>
          </td>
          <td style="width: 32.75%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;"><font style="font-weight: bold;">/s/&#160;</font>Sigal Fattal</div>
          </td>
          <td style="width: 14%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.54%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 32.75%; vertical-align: bottom;">
            <div style="line-height: 1.25;">Name: Sigal Fattal</div>
          </td>
          <td style="width: 14%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.54%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 32.75%; vertical-align: bottom;">
            <div style="line-height: 1.25;">Title: Chief Financial Officer</div>
          </td>
          <td style="width: 14%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 3 -</font></div>
  </div>
  <div style="text-align: center;" id="DSPFPageNumberArea">
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
